Induction chemotherapy for patients with Locally advanced triple negative breast cancer.

被引：0
|
作者：
Ignatova, Ekaterina [1 ]
Frolova, Mona [1 ]
Stenina, Marina B. [1 ]
Petrovsky, Alexander [1 ]
Tjulandin, Sergei [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12573
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Primary Chemotherapy with Bevacizumab for Locally Advanced Triple Negative Breast Cancer
    Carpenter, J.
    Falkson, C.
    Nabell, L.
    De Los Santos, J.
    Krontiras, H.
    Bland, K.
    Li, Y.
    Bae, S.
    [J]. BREAST, 2023, 68 : S61 - S61
  • [3] Cancer-testis antigens in triple-negative and locally advanced breast cancer.
    Harris, Samuel John
    Turner, Natalie Heather
    Chionh, Fiona J. M.
    Walkiewicz, Marzena
    Chakrabarti, Anannya
    Deb, Siddhartha
    Cebon, Jonathan S.
    White, Shane
    John, Tom
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Triple Induction Chemotherapy and Chemoradiotherapy for Locally Advanced Esophageal Cancer. A Phase II Study
    Eisterer, Wolfgang
    De Vries, Alexander
    Kendler, Dorota
    Spechtenhauser, Bernhard
    Koenigsrainer, Alfred
    Nehoda, Hermann
    Virgolini, Irene
    Lukas, Peter
    Bechter, Oliver
    Woell, Ewald
    Oefner, Dietmar
    [J]. ANTICANCER RESEARCH, 2011, 31 (12) : 4407 - 4412
  • [6] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Differential response of neoadjuvant chemotherapy with taxane-carboplatin versus taxane-epirubicin in patients with locally advanced triple-negative breast cancer.
    Wang, Jiayu
    Xu, Binghe
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Ma, Fei
    Fan, Ying
    Luo, Yang
    Cai, Ruigang
    Li, Qiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Dose-intensive chemotherapy for locally advanced breast cancer.
    Schrama J.G.
    Rodenhuis S.
    [J]. Current Oncology Reports, 1999, 1 (1) : 23 - 30
  • [9] Predicitve factors for neoadjuvant chemotherapy in locally advanced breast cancer.
    Perez, MA
    Ruiz, J
    Astudillo, H
    Silva, M
    Silva, J
    Pluma, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 91S - 91S
  • [10] Neoadjuvant chemotherapy carboplatin - taxane response in locally advanced triple negative breast cancer patients in relation to molecular biomarkers
    Sad, L. M.
    Younis, S.
    Abd El Hak, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345